IL31981A - Means and process for determining aldoses - Google Patents

Means and process for determining aldoses

Info

Publication number: IL31981A
Authority: IL; Israel
Prior art keywords: parts; weight; agent; agent according; acid
Prior art date: 1968-05-02

Application number

IL31981A

Other languages

English (en)

Hebrew (he)

Other versions

IL31981A0 (en

Original Assignee

Merck Ag E

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1968-05-02

Filing date

1969-04-08

Publication date

1973-05-31

1969-04-08 Application filed by Merck Ag E filed Critical Merck Ag E

1969-06-25 Publication of IL31981A0 publication Critical patent/IL31981A0/xx

1973-05-31 Publication of IL31981A publication Critical patent/IL31981A/en

Links

238000000034 method Methods 0.000 title claims description 21
150000001323 aldoses Chemical class 0.000 title claims description 17
239000003795 chemical substances by application Substances 0.000 claims description 95
239000002253 acid Substances 0.000 claims description 37
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 36
239000000203 mixture Substances 0.000 claims description 36
UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 claims description 32
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical group OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 27
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 24
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 24
125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 22
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
229960000583 acetic acid Drugs 0.000 claims description 17
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 16
239000012362 glacial acetic acid Substances 0.000 claims description 15
239000001630 malic acid Substances 0.000 claims description 14
BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 13
BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 13
235000011090 malic acid Nutrition 0.000 claims description 13
230000008033 biological extinction Effects 0.000 claims description 12
239000004310 lactic acid Substances 0.000 claims description 12
235000014655 lactic acid Nutrition 0.000 claims description 12
229930182830 galactose Natural products 0.000 claims description 11
239000003960 organic solvent Substances 0.000 claims description 10
238000009835 boiling Methods 0.000 claims description 9
125000003118 aryl group Chemical group 0.000 claims description 7
FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 6
150000004982 aromatic amines Chemical class 0.000 claims description 6
210000001124 body fluid Anatomy 0.000 claims description 6
239000010839 body fluid Substances 0.000 claims description 6
150000001735 carboxylic acids Chemical class 0.000 claims description 6
239000011975 tartaric acid Substances 0.000 claims description 6
235000002906 tartaric acid Nutrition 0.000 claims description 5
230000008569 process Effects 0.000 claims description 4
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 3
125000000217 alkyl group Chemical group 0.000 claims description 3
MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 claims 1
ZGUPUXKLBCQBNM-UHFFFAOYSA-N ethene;ethoxyethane Chemical group C=C.CCOCC ZGUPUXKLBCQBNM-UHFFFAOYSA-N 0.000 claims 1
239000012530 fluid Substances 0.000 claims 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 claims 1
125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 claims 1
RNVCVTLRINQCPJ-UHFFFAOYSA-N o-toluidine Chemical compound CC1=CC=CC=C1N RNVCVTLRINQCPJ-UHFFFAOYSA-N 0.000 description 32
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 28
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 28
239000008103 glucose Substances 0.000 description 28
SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 22
150000007513 acids Chemical class 0.000 description 16
239000003153 chemical reaction reagent Substances 0.000 description 16
XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 14
238000006243 chemical reaction Methods 0.000 description 13
PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 11
SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 11
239000000549 coloured material Substances 0.000 description 11
238000005259 measurement Methods 0.000 description 11
-1 for example Proteins 0.000 description 10
239000000523 sample Substances 0.000 description 10
WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 9
210000004369 blood Anatomy 0.000 description 9
239000008280 blood Substances 0.000 description 9
PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 8
YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 8
150000001412 amines Chemical class 0.000 description 7
125000004432 carbon atom Chemical group C* 0.000 description 7
238000001816 cooling Methods 0.000 description 7
YPFDHNVEDLHUCE-UHFFFAOYSA-N propane-1,3-diol Chemical compound OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 7
108010015776 Glucose oxidase Proteins 0.000 description 6
239000004366 Glucose oxidase Substances 0.000 description 6
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
230000015572 biosynthetic process Effects 0.000 description 6
229940116332 glucose oxidase Drugs 0.000 description 6
235000019420 glucose oxidase Nutrition 0.000 description 6
210000002700 urine Anatomy 0.000 description 6
ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 5
FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 5
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 5
WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 5
BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 5
210000002966 serum Anatomy 0.000 description 5
229960001367 tartaric acid Drugs 0.000 description 5
150000003628 tricarboxylic acids Chemical class 0.000 description 5
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 4
229960004063 propylene glycol Drugs 0.000 description 4
229960004889 salicylic acid Drugs 0.000 description 4
235000000346 sugar Nutrition 0.000 description 4
DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical class CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 3
UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 3
150000001298 alcohols Chemical class 0.000 description 3
150000001312 aldohexoses Chemical class 0.000 description 3
230000004075 alteration Effects 0.000 description 3
238000004458 analytical method Methods 0.000 description 3
230000008901 benefit Effects 0.000 description 3
BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 3
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
150000001875 compounds Chemical class 0.000 description 3
150000002009 diols Chemical class 0.000 description 3
150000002148 esters Chemical class 0.000 description 3
238000010438 heat treatment Methods 0.000 description 3
210000002381 plasma Anatomy 0.000 description 3
230000035945 sensitivity Effects 0.000 description 3
239000002904 solvent Substances 0.000 description 3
239000006228 supernatant Substances 0.000 description 3
238000012360 testing method Methods 0.000 description 3
YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 3
MLPVBIWIRCKMJV-UHFFFAOYSA-N 2-ethylaniline Chemical compound CCC1=CC=CC=C1N MLPVBIWIRCKMJV-UHFFFAOYSA-N 0.000 description 2
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
108090000790 Enzymes Proteins 0.000 description 2
102000004190 Enzymes Human genes 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
COQLPRJCUIATTQ-UHFFFAOYSA-N Uranyl acetate Chemical compound O.O.O=[U]=O.CC(O)=O.CC(O)=O COQLPRJCUIATTQ-UHFFFAOYSA-N 0.000 description 2
150000001320 aldopentoses Chemical class 0.000 description 2
238000006701 autoxidation reaction Methods 0.000 description 2
230000006378 damage Effects 0.000 description 2
206010012601 diabetes mellitus Diseases 0.000 description 2
150000001991 dicarboxylic acids Chemical class 0.000 description 2
DMBHHRLKUKUOEG-UHFFFAOYSA-N diphenylamine Chemical compound C=1C=CC=CC=1NC1=CC=CC=C1 DMBHHRLKUKUOEG-UHFFFAOYSA-N 0.000 description 2
229940088598 enzyme Drugs 0.000 description 2
150000002402 hexoses Chemical class 0.000 description 2
239000000463 material Substances 0.000 description 2
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
150000002763 monocarboxylic acids Chemical class 0.000 description 2
MRIXVKKOHPQOFK-UHFFFAOYSA-N p-methoxysalicylic acid Natural products COC1=CC=C(C(O)=O)C(O)=C1 MRIXVKKOHPQOFK-UHFFFAOYSA-N 0.000 description 2
150000002972 pentoses Chemical class 0.000 description 2
VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
239000008363 phosphate buffer Substances 0.000 description 2
238000002360 preparation method Methods 0.000 description 2
239000000047 product Substances 0.000 description 2
230000001603 reducing effect Effects 0.000 description 2
230000009467 reduction Effects 0.000 description 2
150000008163 sugars Chemical class 0.000 description 2
BJEPYKJPYRNKOW-UWTATZPHSA-N (R)-malic acid Chemical compound OC(=O)[C@H](O)CC(O)=O BJEPYKJPYRNKOW-UWTATZPHSA-N 0.000 description 1
LYCAIKOWRPUZTN-NMQOAUCRSA-N 1,2-dideuteriooxyethane Chemical compound [2H]OCCO[2H] LYCAIKOWRPUZTN-NMQOAUCRSA-N 0.000 description 1
RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
NBKTWPJEIBKCIB-UHFFFAOYSA-N 2,3-diethylaniline Chemical compound CCC1=CC=CC(N)=C1CC NBKTWPJEIBKCIB-UHFFFAOYSA-N 0.000 description 1
VBUBGTCJRMYYRA-UHFFFAOYSA-N 2,5-diethylaniline Chemical compound CCC1=CC=C(CC)C(N)=C1 VBUBGTCJRMYYRA-UHFFFAOYSA-N 0.000 description 1
YKOLZVXSPGIIBJ-UHFFFAOYSA-N 2-Isopropylaniline Chemical compound CC(C)C1=CC=CC=C1N YKOLZVXSPGIIBJ-UHFFFAOYSA-N 0.000 description 1
YSJWNEDBIWZWOI-UHFFFAOYSA-N 2-hydroxy-3,4-dimethylbenzoic acid Chemical compound CC1=CC=C(C(O)=O)C(O)=C1C YSJWNEDBIWZWOI-UHFFFAOYSA-N 0.000 description 1
WKURVXXDGMYSDP-UHFFFAOYSA-N 2-propyl-aniline Chemical compound CCCC1=CC=CC=C1N WKURVXXDGMYSDP-UHFFFAOYSA-N 0.000 description 1
239000005711 Benzoic acid Substances 0.000 description 1
WPYMKLBDIGXBTP-UHFFFAOYSA-N Benzoic acid Natural products OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
229930091371 Fructose Natural products 0.000 description 1
RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
239000005715 Fructose Substances 0.000 description 1
208000007976 Ketosis Diseases 0.000 description 1
FEWJPZIEWOKRBE-XIXRPRMCSA-N Mesotartaric acid Chemical compound OC(=O)[C@@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-XIXRPRMCSA-N 0.000 description 1
241000193803 Therea Species 0.000 description 1
229960004909 aminosalicylic acid Drugs 0.000 description 1
125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
235000010323 ascorbic acid Nutrition 0.000 description 1
229960005070 ascorbic acid Drugs 0.000 description 1
239000011668 ascorbic acid Substances 0.000 description 1
WXBLLCUINBKULX-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1.OC(=O)C1=CC=CC=C1 WXBLLCUINBKULX-UHFFFAOYSA-N 0.000 description 1
235000010233 benzoic acid Nutrition 0.000 description 1
239000012496 blank sample Substances 0.000 description 1
150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
238000004140 cleaning Methods 0.000 description 1
239000003086 colorant Substances 0.000 description 1
238000002425 crystallisation Methods 0.000 description 1
229960001270 d- tartaric acid Drugs 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
238000003745 diagnosis Methods 0.000 description 1
238000010586 diagram Methods 0.000 description 1
238000004821 distillation Methods 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
238000006911 enzymatic reaction Methods 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
239000000174 gluconic acid Substances 0.000 description 1
235000012208 gluconic acid Nutrition 0.000 description 1
150000002334 glycols Chemical class 0.000 description 1
230000002414 glycolytic effect Effects 0.000 description 1
230000006872 improvement Effects 0.000 description 1
229910001867 inorganic solvent Inorganic materials 0.000 description 1
239000003049 inorganic solvent Substances 0.000 description 1
238000011835 investigation Methods 0.000 description 1
230000000622 irritating effect Effects 0.000 description 1
125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
150000002584 ketoses Chemical class 0.000 description 1
230000002503 metabolic effect Effects 0.000 description 1
150000004702 methyl esters Chemical class 0.000 description 1
150000007522 mineralic acids Chemical class 0.000 description 1
VSHTWPWTCXQLQN-UHFFFAOYSA-N n-butylaniline Chemical compound CCCCNC1=CC=CC=C1 VSHTWPWTCXQLQN-UHFFFAOYSA-N 0.000 description 1
125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
230000003647 oxidation Effects 0.000 description 1
238000007254 oxidation reaction Methods 0.000 description 1
238000004816 paper chromatography Methods 0.000 description 1
229920005862 polyol Polymers 0.000 description 1
150000003077 polyols Chemical class 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
230000035484 reaction time Effects 0.000 description 1
238000011946 reduction process Methods 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
238000003860 storage Methods 0.000 description 1
239000000126 substance Substances 0.000 description 1
125000000446 sulfanediyl group Chemical group *S* 0.000 description 1
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
238000004809 thin layer chromatography Methods 0.000 description 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]
- Y10T436/144444—Glucose

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Hematology (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Urology & Nephrology (AREA)
Immunology (AREA)
Biotechnology (AREA)
Analytical Chemistry (AREA)
Cell Biology (AREA)
Diabetes (AREA)
Food Science & Technology (AREA)
Medicinal Chemistry (AREA)
Physics & Mathematics (AREA)
Microbiology (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Investigating Or Analysing Biological Materials (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Saccharide Compounds (AREA)
Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)

IL31981A 1968-05-02 1969-04-08 Means and process for determining aldoses IL31981A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE1773330A DE1773330C2 (de)	1968-05-02	1968-05-02	Reagenz und Verfahren zur Bestimmung von Aldosen

Publications (2)

Publication Number	Publication Date
IL31981A0 IL31981A0 (en)	1969-06-25
IL31981A true IL31981A (en)	1973-05-31

Family

ID=5701643

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL31981A IL31981A (en)	1968-05-02	1969-04-08	Means and process for determining aldoses

Country Status (9)

Country	Link
US (1)	US3607077A (de)
BE (1)	BE732223A (de)
CH (1)	CH507519A (de)
DE (1)	DE1773330C2 (de)
FR (1)	FR2007637A1 (de)
GB (1)	GB1248624A (de)
IL (1)	IL31981A (de)
NL (1)	NL6906734A (de)
SE (1)	SE346387B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH0687062B2 (ja) *	1985-05-10	1994-11-02	株式会社京都医科学研究所	血液中の解糖阻止方法
FR3112815A1 (fr)	2020-07-21	2022-01-28	Psa Automobiles Sa	Procede de correction d’une derive de mesure de richesse

1968
- 1968-05-02 DE DE1773330A patent/DE1773330C2/de not_active Expired
1969
- 1969-04-08 IL IL31981A patent/IL31981A/en unknown
- 1969-04-09 GB GB08227/69A patent/GB1248624A/en not_active Expired
- 1969-04-10 CH CH548569A patent/CH507519A/de not_active IP Right Cessation
- 1969-04-25 FR FR6913137A patent/FR2007637A1/fr not_active Withdrawn
- 1969-04-28 BE BE732223D patent/BE732223A/xx unknown
- 1969-04-29 US US820289A patent/US3607077A/en not_active Expired - Lifetime
- 1969-04-29 SE SE6090/69*A patent/SE346387B/xx unknown
- 1969-05-02 NL NL6906734A patent/NL6906734A/xx unknown

Also Published As

Publication number	Publication date
NL6906734A (de)	1969-11-04
US3607077A (en)	1971-09-21
FR2007637A1 (de)	1970-01-09
CH507519A (de)	1971-05-15
GB1248624A (en)	1971-10-06
DE1773330B1 (de)	1972-01-20
SE346387B (de)	1972-07-03
BE732223A (de)	1969-10-28
IL31981A0 (en)	1969-06-25
DE1773330C2 (de)	1975-03-27

Publication	Publication Date	Title
Bueding	1949	Studies on the metabolism of the filarial worm, Litomosoides carinii
Ashwell	1966	[6] New colorimetric methods of sugar analysis
Johnson et al.	1977	Dissolved carbohydrates in seawater. I, A precise spectrophotometric analysis for monosaccharides
Rajarathnam et al.	1989	Synthesis, location, and lateral mobility of fluorescently labeled ubiquinone 10 in mitochondrial and artificial membranes
Schuldiner et al.	1975	Energy-dependent binding of dansylgalactosides to the beta-galactoside carrier protein.
Slater et al.	1946	A modification of the fluorimetric method of determining riboflavin in biological materials
Trnková et al.	2013	Green tea catechins can bind and modify ERp57/PDIA3 activity
Singh et al.	1979	A highly sensitive and rapid fluorometric assay for UDP-glucuronyltransferase using 3-hydroxybenzo (a) pyrene as substrate
US3891573A (en)	1975-06-24	Aqueous cholesterol standard solution
US4716119A (en)	1987-12-29	Control serum and process therefor
Strain	1954	Chlorophyll reactions, oxidation and isomerization reactions of chlorophylls in killed leaves
Newcomer et al.	1979	Location of the sugar-binding site of L-arabinose-binding protein. Sugar derivative syntheses, sugar binding specificity, and difference Fourier analyses.
IL31981A (en)	1973-05-31	Means and process for determining aldoses
JPS63246356A (ja)	1988-10-13	新規な尿素誘導体及びこれを発色成分として用いる測定法
US3753863A (en)	1973-08-21	Reagent for medical testing which contains a benzidine-like compound
US3233974A (en)	1966-02-08	Diagnostic compositions
JPH06289015A (ja)	1994-10-18	フェノチアジン系色源体安定化組成物
US4132598A (en)	1979-01-02	Stabilized liquid phosphate containing diagnostic compositions and method of preparing same
Camber	1949	Histochemical demonstration of ketosteroids in the adrenal cortex
Chaby et al.	1974	Colorimetric estimation of 3-deoxy-D-manno-octulosonic acid in oligosaccharides with diphenylamine
Fridovich	1966	Some effects of organic solvents on the reaction kinetics of milk xanthine oxidase
Fink	1982	Some specific fluorogenic reactions in pharmaceutical and environmental applications
Curtis-Prior et al.	1975	A colorimetric method for the determination of deoxyribonucleic acid in adipose tissue
Erikson et al.	1973	1, 4-Dihydro-3, 5-diacetyl lutidine. A basis for triglyceride determination in biological samples
ELMADJIAN	1962	Adrenaline and noradrenaline